Screener
Prime Medicine PRME Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands, except share and per share amounts) | June 30,2026 | December 31,2025 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $47,451 | $63,032 |
| Short-term investments | 47,620 | 114,648 |
| Prepaid expenses | 1,357 | 2,939 |
| Other current assets | 376 | 674 |
| Total current assets | 96,804 | 181,293 |
| Property and equipment, net | 17,077 | 20,572 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's short-term investments?
- Prime Medicine (PRME) reported short-term investments of $47.62M in Q2 2026.
- What is the long-term trend for Prime Medicine's short-term investments?
- Over 2 years (2021 to 2025), Prime Medicine's short-term investments has grown at a 29.6% compound annual growth rate (CAGR), from $68.24M to $114.65M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.
Ask your AI about Prime Medicine's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude